NCT07002580 Evaluation of the Effectiveness of iPACK and Adductor Canal Blocks on Patients Undergoing Arthroscopic Knee Surgery
| NCT ID | NCT07002580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sakarya University |
| Condition | Patients Undergoing Arthroscopic Knee Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-07-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Arthroscopic knee surgery is one of the most commonly performed procedures in orthopedic surgery. More than 50% of patients experience moderate to severe pain after the operation. Inadequate postoperative pain control and poor recovery quality can negatively impact physiotherapy protocols, prolong hospital stays, and consequently lead to cognitive dysfunction, systemic infections, and increased healthcare costs. Therefore, reducing postoperative pain and improving recovery quality are of great importance. In our clinic, a variety of analgesic techniques are routinely employed as part of a multimodal analgesia approach for patients undergoing arthroscopic knee surgery. One of these techniques is the simultaneous application of the IPACK block and the adductor canal block. In this study, we aim to evaluate the effectiveness of these blocks on postoperative recovery quality in patients undergoing arthroscopic knee surgery.
Eligibility Criteria
Inclusion Criteria: * Patients aged between 18 and 50 years, * Scheduled for arthroscopic knee surgery under spinal anesthesia due to knee pathology * Patients classified as ASA physical status I-II-III according to the American Society of Anesthesiologists risk classification Exclusion Criteria: * Coagulopathy * ASA IV-V patients * Uncooperable patients * Patients who refuses to participate in study * Patients who takes chronic pain treatments
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07002580 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Patients Undergoing Arthroscopic Knee Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07002580 currently recruiting?
Yes, NCT07002580 is actively recruiting participants. Contact the research team at dr.oguzhanokumusss@gmail.com for enrollment information.
Where is the NCT07002580 trial being conducted?
This trial is being conducted at Sakarya, Turkey (Türkiye).
Who is sponsoring the NCT07002580 clinical trial?
NCT07002580 is sponsored by Sakarya University. The trial plans to enroll 64 participants.